Clinical Trials Directory

Trials / Completed

CompletedNCT04573244

Hemoglobin Easy Measurement With Optical Artificial Intelligence

A Prospective Feasibility Study to Explore the Utility of Using a Smartphone Camera to Monitor Blood Hemoglobin Levels in Children and Adolescents

Status
Completed
Phase
Study type
Observational
Enrollment
823 (actual)
Sponsor
MYOR Ltd. · Industry
Sex
All
Age
6 Months – 18 Years
Healthy volunteers
Accepted

Summary

Blood hemoglobin levels are an extremely important measure for a large swath of medical procedures as they reflect the oxygen-carrying capacity of human blood. The gold standard measure for blood hemoglobin levels involve a venous blood draw followed by a laboratory-based complete blood count (CBC), a process which is both painful and time consuming. To date, various methodologies have been tested to either expediate the process or provide a non-invasive alternative. There remains a need to provide a quick, pain-free/non-invasive and accurate modality to measure blood hemoglobin levels. The objective of this study is to determine whether computer vision technologies can be applied to fingernail images captured via a smartphone camera to quantify blood hemoglobin levels.

Conditions

Timeline

Start date
2020-12-02
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2020-10-05
Last updated
2024-08-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04573244. Inclusion in this directory is not an endorsement.

Hemoglobin Easy Measurement With Optical Artificial Intelligence (NCT04573244) · Clinical Trials Directory